Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 6, 2025 • 10:01 PM ET

Date/Time Source News Release
03/31/2025 08:30 AM EDT GlobeNewswire LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
03/27/2025 08:30 AM EDT GlobeNewswire LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
03/10/2025 08:30 AM EDT GlobeNewswire New Findings Show how LIXTE's Lead Clinical Compound, LB-100, is Metabolized to its Active Form
02/25/2025 08:30 AM EST GlobeNewswire LIXTE Adds Northwestern University's Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
02/13/2025 10:35 AM EST GlobeNewswire LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
02/11/2025 08:42 AM EST GlobeNewswire LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
02/10/2025 05:00 PM EST GlobeNewswire LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement
09/11/2024 01:00 PM EDT ACCESSWIRE Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
09/04/2024 08:30 AM EDT GlobeNewswire LIXTE Receives U.S. Patent Issue Notification for Immune Oncology
08/26/2024 08:30 AM EDT GlobeNewswire First Patient Dosed with LIXTE's LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company
Page

Additional News

As of June 6, 2025 • 10:01 PM ET

Date/Time Source News Release
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Lixte Biotechnology Holdings Inc.
04/04/2025 04:17 PM EDT SeekingAlpha Lixte Biotechnology files to sell 467,393 shares of common stock by selling shareholders
03/18/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 18th, 2025
03/18/2025 05:31 AM EDT US Earnings Reports Expected earnings - Lixte Biotechnology Holdings Inc.
02/11/2025 09:19 AM EST SeekingAlpha LIXTE Biotechnology announces $1.05M registered direct offering; shares fall
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Lixte Biotechnology Holdings Inc.
10/29/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Oct 29, 2024 as of 4:00 pm ET
10/29/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Tue, Oct 29, 2024 as of 10.00 am ET
10/23/2024 07:23 AM EDT SeekingAlpha Lixte Biotechnology files to sell units, no amount given
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.